These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 33058053
1. Botulinum toxin injection in the management of chronic migraine: the Saudi experience with a proposal for a new protocol. Algahtani H, Shirah B, Sukkar G, Bukhari H, Meftah I, Alhazmi A, Alshareef A, Algethami A, Alshanqiti A, Andeejani M. Acta Neurol Belg; 2021 Dec; 121(6):1783-1787. PubMed ID: 33058053 [Abstract] [Full Text] [Related]
2. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Silberstein S, Mathew N, Saper J, Jenkins S. Headache; 2000 Jun; 40(6):445-50. PubMed ID: 10849039 [Abstract] [Full Text] [Related]
3. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology]. Bernhard MK, Bertsche A, Syrbe S, Weise S, Merkenschlager A. Fortschr Neurol Psychiatr; 2014 Jan; 82(1):39-42. PubMed ID: 24446117 [Abstract] [Full Text] [Related]
8. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization. Mitchell MP, Schaecher K, Cannon HE, Speckman M. J Manag Care Pharm; 2008 Jun; 14(5):442-50. PubMed ID: 18597573 [Abstract] [Full Text] [Related]
20. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial. Pijpers JA, Kies DA, Louter MA, van Zwet EW, Ferrari MD, Terwindt GM. Brain; 2019 May 01; 142(5):1203-1214. PubMed ID: 30982843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]